#BetaBlockers

A new laboratory study suggests cheap beta-blocker drugs can slow the spread of triple-negative breast cancer.
The finding could change treatment strategies for a hard-to-treat cancer subtype worldwide. ( Monash University press release )

Triple-negative breast cancer, or TNBC, lacks three common receptors.
Doctors find TNBC hard to treat with hormone or HER2-targeted therapies. ( World Journal review on TNBC prevalence and challenges )

The Monash University team studied how beta-2 adrenoceptor signals drive TNBC invasion.
They found a regulatory gene called HOXC12 helps couple the receptor to pro-invasion signals. ( Monash University press release )